(Q41517471)

2 October 2017

1 reference

title

Management of lipid disorders in the elderly (English)

1 reference

2 October 2017

Playford DA

1

1 reference

2 October 2017

Watts GF

series ordinal

2

1 reference

2 October 2017

publication date

1 June 1997

1 reference

2 October 2017

1 reference

2 October 2017

volume

10

1 reference

2 October 2017

issue

6

1 reference

2 October 2017

page(s)

444-462

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199710060-00005

2 October 2017

exact match

0 references

cites work

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy.

1 reference

12 December 2020

Abdominal obesity as important component of insulin-resistance syndrome

1 reference

12 December 2020

Interactions with hydroxymethylglutaryl-coenzyme A reductase inhibitors

1 reference

12 December 2020

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins

1 reference

12 December 2020

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

12 December 2020

Differential changes in plasma high-density lipoprotein-cholesterol levels in obese men and women during weight reduction

1 reference

12 December 2020

Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain

1 reference

12 December 2020

Apolipoprotein A-I containing lipoproteins in coronary artery disease

1 reference

12 December 2020

Vitamin E and coronary heart disease: the European paradox

1 reference

12 December 2020

The sex difference in ischemic heart disease

1 reference

12 December 2020

Alcohol consumption and risk of coronary heart disease. Studies suggest that wine has additional effect to that of ethanol

1 reference

12 December 2020

Effects of National Cholesterol Education Program Step 2 diets relatively high or relatively low in fish-derived fatty acids on plasma lipoproteins in middle-aged and elderly subjects.

1 reference

12 December 2020

Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women.

1 reference

12 December 2020

Progesterone and modulation of endothelium-dependent responses in canine coronary arteries

1 reference

12 December 2020

Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman

1 reference

12 December 2020

Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators.

1 reference

12 December 2020

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

1 reference

12 December 2020

Drug therapy of hypercholesterolemia

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events

1 reference

12 December 2020

High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use

1 reference

12 December 2020

Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?

1 reference

12 December 2020

Relative survival benefits of risk factor modifications

1 reference

12 December 2020

New developments in the use of niacin for treatment of hyperlipidemia: new considerations in the use of an old drug.

1 reference

12 December 2020

Post-Heparin Plasma Lipoprotein Lipase and Hepatic Lipase in Normal Subjects and in Patients with Hypertriglyceridaemia: Correlations to Sex, Age and Various Parameters of Triglyceride Metabolism

1 reference

12 December 2020

Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women

1 reference

12 December 2020

Guidelines for counseling postmenopausal women about preventive hormone therapy. American College of Physicians

1 reference

12 December 2020

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

1 reference

12 December 2020

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

1 reference

12 December 2020

Are the effects of cholesterol lowering drugs always equal?

1 reference

12 December 2020

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

1 reference

12 December 2020

The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population

1 reference

12 December 2020

Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region

1 reference

12 December 2020

Epidemiology of triglycerides: a view from Framingham

1 reference

12 December 2020

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

12 December 2020

Antihyperlipidaemic agents. Drug interactions of clinical significance

1 reference

12 December 2020

The role of isoprenoids in vascular smooth muscle: potential benefits of statins unrelated to cholesterol lowering

1 reference

12 December 2020

Aging, natural death, and the compression of morbidity

1 reference

12 December 2020

The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement

1 reference

12 December 2020

Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis

1 reference

12 December 2020

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study

1 reference

12 December 2020

Dietary influences on serum lipids and lipoproteins

1 reference

12 December 2020

Polyunsaturated fatty acids and function of platelets and endothelial cells

1 reference

12 December 2020

Effects of fenofibrate on angiographically examined coronary atherosclerosis and left ventricular function in hypercholesterolemic patients

1 reference

12 December 2020

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

1 reference

12 December 2020

Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis

1 reference

12 December 2020

Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial

1 reference

12 December 2020

Dietary fats and coronary heart disease

1 reference

12 December 2020

Dyslipoproteinemia in the elderly. Should it be treated?

1 reference

12 December 2020

Long-term safety and efficacy profile of simvastatin

1 reference

12 December 2020

Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications.

1 reference

12 December 2020

Aging and atherosclerosis. Teasing out the contributions of time, secondary aging, and primary aging

1 reference

12 December 2020

Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians

1 reference

12 December 2020

Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease

1 reference

12 December 2020

Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women

1 reference

12 December 2020

Diabetes and atherosclerosis: an epidemiologic view

1 reference

12 December 2020

Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

1 reference

12 December 2020

Wine, alcohol, platelets, and the French paradox for coronary heart disease

1 reference

12 December 2020

Estrogen and coronary heart disease in women

1 reference

12 December 2020

Characteristics and outcomes of hospitalized older patients who develop hypocholesterolemia

1 reference

12 December 2020

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

12 December 2020

Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. The Lipid Research Clinics Program Epidemiology Committee

1 reference

12 December 2020

Dyslipoproteinemia in women and the elderly.

1 reference

12 December 2020

The triglyceride issue revisited. Findings from the Helsinki Heart Study.

1 reference

12 December 2020

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

1 reference

12 December 2020

Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys

1 reference

12 December 2020

Cost of prevention. The case of lipid lowering

1 reference

12 December 2020

Why cardiologists must be interested in lipids

1 reference

12 December 2020

Ischemic heart disease risk factors after age 50.

1 reference

12 December 2020

Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.

1 reference

12 December 2020

Peripheral artery disease and cardiovascular risk factors in the elderly. The Honolulu Heart Program

1 reference

12 December 2020

Lipid and lipoprotein predictors of coronary heart disease in elderly men in the Honolulu Heart Program

1 reference

12 December 2020

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

1 reference

12 December 2020

The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)

1 reference

12 December 2020

Estimated effects of reducing dietary saturated fat intake on the incidence and costs of coronary heart disease in the United States

1 reference

12 December 2020

High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study

1 reference

12 December 2020

Health promotion and the compression of morbidity

1 reference

12 December 2020

[Relationship between plasma antioxidants and coronary artery disease]

1 reference

12 December 2020

Fish consumption, fish oil, lipids, and coronary heart disease

1 reference

12 December 2020

Effects of unsaturated fatty acids on blood clotting and fibrinolysis

1 reference

12 December 2020

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

12 December 2020

Primary prevention of stroke

1 reference

12 December 2020

Nitric oxide: physiology, pathophysiology, and pharmacology

1 reference

12 December 2020

Atherosclerosis and aging

1 reference

12 December 2020

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

1 reference

12 December 2020

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts

1 reference

12 December 2020

Antioxidant vitamin-cardiovascular disease hypothesis is still promising, but still unproven: the need for randomized trials

1 reference

12 December 2020

Treating high blood cholesterol in the older patient

1 reference

12 December 2020

Diet, antioxidant vitamins, oxidative stress and risk of coronary artery disease: the Peerzada Prospective Study.

1 reference

12 December 2020

Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomised controlled trial

1 reference

12 December 2020

Cholesterol lowering in the elderly. Results of the Cholesterol Reduction in Seniors Program (CRISP) pilot study

1 reference

12 December 2020

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

12 December 2020

The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females

1 reference

12 December 2020

High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering

1 reference

12 December 2020

Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease

1 reference

12 December 2020

Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia

1 reference

12 December 2020

Pathophysiology of microvascular disease in non-insulin-dependent diabetes

1 reference

12 December 2020

Menopause and the risk of coronary heart disease in women

1 reference

12 December 2020

On the associations of body cholesterol pool size with age, HDL cholesterol and plasma total cholesterol concentration in humans

1 reference

12 December 2020

Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma

1 reference

12 December 2020

Statins do more than just lower cholesterol

1 reference

12 December 2020

Lower patient's cholesterol now. Trial evidence shows clear benefits from secondary prevention. 1995.

1 reference

12 December 2020

Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function.

1 reference

12 December 2020

Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study

1 reference

12 December 2020

Menopause and heart disease. A review

1 reference

12 December 2020

Evolving natural history of coronary artery disease in diabetes mellitus

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

12 December 2020

Review of clinical trials: proving the lipid hypothesis

1 reference

12 December 2020

High blood cholesterol in elderly men and the excess risk for coronary heart disease

1 reference

12 December 2020

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

12 December 2020

The cardioprotective effects of moderate alcohol consumption

1 reference

12 December 2020

Longitudinal changes in serum cholesterol in man: an epidemiologic search for an etiology

1 reference

12 December 2020

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

1 reference

12 December 2020

Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)

1 reference

12 December 2020

Cholesterol lowering does have a role in secondary prevention

1 reference

12 December 2020

Cholesterol reduction yields clinical benefit. A new look at old data

1 reference

12 December 2020

Antecedents of death in the men of a Veterans Administration nursing home

1 reference

12 December 2020

The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women

1 reference

12 December 2020

Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study

1 reference

12 December 2020

Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity

1 reference

12 December 2020

Associations of serum high density lipoprotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10 000 men

1 reference

12 December 2020

Dietary fish oil and blood lipids

1 reference

12 December 2020

Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus

1 reference

12 December 2020

The effect of serum lipid regulation on the development of femoral atherosclerosis in hyperlipidaemia: a non-randomized controlled study

1 reference

12 December 2020

Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia. The Simvastatin Pravastatin Study Group

1 reference

12 December 2020

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

1 reference

12 December 2020

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

1 reference

12 December 2020

10.2165/00002512-199710060-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

2 October 2017

1041139294

0 references

1 reference